PressBook
March 2025
- Pressbook March 2025
- Comparative Analysis of Clinical Characteristics and Antimicrobial Resistance Between Acinetobacter baumannii and Other Acinetobacter Species
- Carbapenem-resistant Enterobacterales – third update
- Acinetobacter baumannii Complex Infections: New Treatment Options in the Antibiotic Pipeline
- WHO global research priorities for antimicrobial resistance in human health
- The Evolution of Antimicrobial Resistance in Acinetobacter baumannii and New Strategies to Fight It
- Pooled Antibiotic Susceptibility Testing Performs Within CLSI Standards for Validation When Measured Against Broth Microdilution and Disk Diffusion Antibiotic Susceptibility Testing of Cultured Isolates
- Comparison of carbapenem MIC for NDM-producing Enterobacterales by different AST methods
- Comparison of carbapenem minimum inhibitory concentrations of Oxacillin-48-like Klebsiella pneumoniae by Sensititre, Vitek 2, MicroScan, and Etest
November 2024
- Pressbook November 2024
- CAZ-AVI vs Polymyxin-Based Combination Therapies - A Study on 30-Day Mortality in CRE Bloodstream Infections in an OXA-48-Endemic Region
- Ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae accompanied hypermucoviscosity acquisition
- Global burden of bacterial antimicrobial resistance 1990–2021- a systematic analysis with forecasts to 2050
- In vivo efficacy of enmetazobactam combined with cefepime in a murine pneumonia model induced by OXA-48-producing K pneumoniae
- Insertion sequences within oxaci genes as molecular determinants of A baumannii resistance to carbapenems
- Insights into the Rising Threat of CRE and P.aeruginosa Epidemic Infections in Eastern Europe
- Noncarbapenemase OXA-48 Variants (OXA-163 and OXA-405) Falsely Detected as Carbapenemases by the β Carba Test
- Overview of AMR ESKAPEE pathogens in food sources and their implications form a One Health perspective
- Prevalence, Characterization, and Epidemio Relationships between ESBL &CP E coli, Kpneumoniae, and Acinetobacter spp
July 2024
- Pressbook July 2024
- Genomic insights into and IV evaluation of AM combination therapies for CRAB
- Treatment guidelines for MDR-GN microorganisms
- Carbapenem-Resistant Enterobacteriaceae in Urinary Tract infections from biological insights to emerging therapeutic alternatives
- Characterization of Carbapenemase- and ESBL-Producing GN bacilli isolated from patients with UT and bloostream infections
- Navigating the network - a narrative overview of AMR surveillance and data flow in the USA
- Carbapenem-Resistant K. Pneumoniae in large public acute-care healthcare system NY
- Colonization with ESBL and carbapenemases producing Enterobacteriaceae among hospitalized patients at the global level
- Community carriage of ESBL-producing E coli and K Pneumoniae - a cross-sectional study
April 2024
- Pressbook April 2024
- Antimicrobial resistance : prevalence, economic burden, mechanisms of resistance and strategies to overcome
- Pervasive transmission of a carbapenem resistance plasmid in the gut microbiota of hospitalized patients
- Evaluation of antibiotic resistance mechanisms in Gram-negative bacteria
- A review of carbapenem resistance in enterobacterales and its detection techniques
- Molecular mechanisms of resistance revisited
- Extended-spectrum β-lactamases - an update on their characteristics, epidemiology and detectio
- Global point prevalence survey - Impact and value
- Carbapenem-resistant Escherichia coli exhibit diverse spatiotemporal epidemiological characteristics across the globe
- Global epidemiology of CTX-M-type β-lactam resistance in human and animal
- Prevalence of Carbapenemase and Extended-Spectrum β-Lactamase producing enterobacteriaceae
